Analysts bullish on Teva
More and more analysts are expressing confidence in the stock of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA). Data from “The Wall street Journal” shows that just three months ago the analysts’ consensus on Teva’s share was neutral, whereas today it is positive.
The Israeli pharmaceutical company,